Next-generation probiotics: a promising approach towards designing personalized medicine

References

• Abdo Z, LeCureux J, LaVoy A, Eklund B, Ryan EP, Dean GA. 2019. Impact of oral probiotic Lactobacillus acidophilus vaccine strains on the immune response and gut microbiome of mice. PLoS One. 14(12):e0225842.
   PubMed Web of Science ®Google Scholar
• Adel-Patient K, Ah‐Leung S, Creminon C, Nouaille S, Chatel JM, Langella P, Wal JM. 2005. Oral administration of recombinant Lactococcus lactis expressing bovine beta-lactoglobulin partially prevents mice from sensitization. Clin Exp Allergy. 35(4):539–546.
   PubMed Web of Science ®Google Scholar
• Ansaldo E, Slayden LC, Ching KL, Koch MA, Wolf NK, Plichta DR, Brown EM, Graham DB, Xavier RJ, Moon JJ, et al. 2019. Akkermansia muciniphila induces intestinal adaptive immune responses during homeostasis. Science. 364(6446):1179–1184.
   PubMed Web of Science ®Google Scholar
• Arora M, Baldi A. 2015. Regulatory categories of probiotics across the globe: a review representing existing and recommended categorization. Indian J Med Microbiol. 33(5):2–10.
   PubMedGoogle Scholar
• Arumugam M, Raes J, Pelletier E, Le Paslier D, Yamada T, Mende DR, Fernandes GR, Tap J, Bruls T, Batto JM, et al. 2011. Enterotypes of the human gut microbiome. Nature. 473(7346):174–180.
   PubMed Web of Science ®Google Scholar
• Bárcena C, Valdés-Mas R, Mayoral P, Garabaya C, Durand S, Rodríguez F, Fernández-García MT, Salazar N, Nogacka AM, Garatachea N, et al. 2019. Healthspan and lifespan extension by fecal microbiota transplantation into progeroid mice. Nat Med. 25(8):1234–1242.
   PubMed Web of Science ®Google Scholar
• Barzegari A, Saei AA. 2012. Designing probiotics with respect to the native microbiome. Future Microbiol. 7(5):571–575.
   PubMed Web of Science ®Google Scholar
• Blacher E, Bashiardes S, Shapiro H, Rothschild D, Mor U, Dori-Bachash M, Kleimeyer C, Moresi C, Harnik Y, Zur M, et al. 2019. Potential roles of gut microbiome and metabolites in modulating ALS in mice. Nature. 572(7770):474–480.
   PubMed Web of Science ®Google Scholar
• Boehm AB, Sassoubre LM. 2014. Enterococci as indicators of environmental fecal contamination. In: Glimore MS, Clewell DB, Ike Y, editors. Enterococci: from commensals to leading cause of drug resistant infection. Boston: Massachusetts Eye and Ear Infirmary.
   Google Scholar
• Bohlul E, Hasanlou F, Taromchi AH, Nadri S. 2019. TRAIL-expressing recombinant Lactococcus lactis induces apoptosis in human colon adenocarcinoma SW480 and HCT116 cells. J Appl Microbiol. 126(5):1558–1567.
   PubMed Web of Science ®Google Scholar
• Cai L, Li Q, Deng Y, Liu X, Du W, Jiang X. 2020. Construction and expression of recombinant uricase-expressing genetically engineered bacteria and its application in rat model of hyperuricemia. Int J Mol Med. 45(5):1488–1500.
   PubMed Web of Science ®Google Scholar
• Chaput N, Lepage P, Coutzac C, Soularue E, Le Roux K, Monot C, Boselli L, Routier E, Cassard L, Collins M, et al. 2017. Baseline gut microbiota predicts clinical response and colitis in metastatic melanoma patients treated with ipilimumab. Ann Oncol. 28(6):1368–1379.
   PubMed Web of Science ®Google Scholar
• Chen T, Tian P, Huang Z, Zhao X, Wang H, Xia C, Wang L, Wei H. 2018. Engineered commensal bacteria prevent systemic inflammation-induced memory impairment and amyloidogenesis via producing GLP-1. Appl Microbiol Biotechnol. 102(17):7565–7575.
   PubMed Web of Science ®Google Scholar
• Choi HJ, Ahn JH, Park SH, Do KH, Kim J, Moon Y. 2012. Enhanced wound healing by recombinant Escherichia coli Nissle 1917 via human epidermal growth factor receptor in human intestinal epithelial cells: therapeutic implication using recombinant probiotics. Infect Immun. 80(3):1079–1087.
   PubMed Web of Science ®Google Scholar
• Chua JCL, Hale JDF, Silcock P, Bremer PJ. 2019. Bacterial survival and adhesion for formulating new oral probiotic foods. Crit Rev Food Sci Nutr. 60(17):1–12.
   Web of Science ®Google Scholar
• Daillère R, Vétizou M, Waldschmitt N, Yamazaki T, Isnard C, Poirier-Colame V, Duong CPM, Flament C, Lepage P, Roberti MP, et al. 2016. Enterococcus hirae and Barnesiella intestinihominis facilitate cyclophosphamide-induced therapeutic immunomodulatory effects. Immunity. 45(4):931–943.
   PubMed Web of Science ®Google Scholar
• de Jesus LCL, Lima FA, Coelho-Rocha ND, da Silva TF, Paz J, Azevedo V, Mancha-Agresti P, Drumond MM. 2019. Recombinant probiotics and microbiota modulation as a good therapy for diseases related to the GIT. In: Salanta LC, editor. The health benefits of foods—current knowledge and further development. London: IntechOpen Limited.  DOI:10.5772/intechopen.88325
   Google Scholar
• De Vadder F, Kovatcheva-Datchary P, Zitoun C, Duchampt A, Backhed F, Mithieux G. 2016. Microbiota-produced succinate improves glucose homeostasis via intestinal gluconeogenesis. Cell Metab. 24(1):151–157.
   PubMed Web of Science ®Google Scholar
• Deng H, Li Z, Tan Y, Guo Z, Liu Y, Wang Y, Yuan Y, Yang R, Bi Y, Bai Y, et al. 2016. A novel strain of Bacteroides fragilis enhances phagocytosis and polarises M1 macrophages. Sci Rep. 6:29401.
   PubMed Web of Science ®Google Scholar
• Ding G, Bai J, Feng B, Wang L, Qiao X, Zhou H, Jiang Y, Cui W, Tang L, Li Y, et al. 2019. An EGFP-marked recombinant lactobacillus oral tetravalent vaccine constitutively expressing α, ε, β1, and β2 toxoids for Clostridium perfringens elicits effective anti-toxins protective immunity. Virulence. 10(1):754–767.
   PubMed Web of Science ®Google Scholar
• Duan FF, Liu JH, March JC. 2015. Engineered commensal bacteria reprogram intestinal cells into glucose-responsive insulin-secreting cells for the treatment of diabetes. Diabetes. 64(5):1794–1803.
   PubMed Web of Science ®Google Scholar
• Duncan SH, Hold GL, Harmsen HJ, Stewart CS, Flint HJ. 2002. Growth requirements and fermentation products of Fusobacterium prausnitzii, and a proposal to reclassify it as Faecalibacterium prausnitzii gen. nov., comb. nov. Int J Syst Evol Microbiol. 52:2141–2146.
   PubMed Web of Science ®Google Scholar
• Engels C, Ruscheweyh HJ, Beerenwinkel N, Lacroix C, Schwab C. 2016. The common gut microbe Eubacterium hallii also contributes to intestinal propionate formation. Front Microbiol. 7:713.
   PubMed Web of Science ®Google Scholar
• Feng Q, Chen WD, Wang YD. 2018. Gut microbiota: an integral moderator in health and disease. Front Microbiol. 9:151.
   PubMed Web of Science ®Google Scholar
• Fuller R. 1989. Probiotics in man and animals. J Appl Bacteriol. 66(5):365–378.
   PubMedGoogle Scholar
• Gauffin CP, Santacruz A, Moya Á, Sanz Y. 2012. Bacteroides uniformis CECT 7771 ameliorates metabolic and immunological dysfunction in mice with high-fat-diet induced obesity. PLoS One. 7(7):e41079.
   PubMed Web of Science ®Google Scholar
• Gerard P, Lepercq P, Leclerc M, Gavini F, Raibaud P, Juste C. 2007. Bacteroides sp. strain D8, the first cholesterol-reducing bacterium isolated from human feces. Appl Environ Microbiol. 73(18):5742–5749.
   PubMed Web of Science ®Google Scholar
• Goodrich JK, Davenport ER, Beaumont M, Jackson MA, Knight R, Ober C, Spector TD, Bell JT, Clark AG, Ley RE. 2016. Genetic determinants of the gut microbiome in UK twins. Cell Host Microbe. 19(5):731–743.
   PubMed Web of Science ®Google Scholar
• Goodrich JK, Waters JL, Poole AC, Sutter JL, Koren O, Blekhman R, Beaumont M, Van Treuren W, Knight R, Bell JT, et al. 2014. Human genetics shape the gut microbiome. Cell. 159(4):789–799.
   PubMed Web of Science ®Google Scholar
• Gopalakrishnan V, Spencer CN, Nezi L, Reuben A, Andrews MC, Karpinets TV, Prieto PA, Vicente D, Hoffman K, Wei SC, et al. 2018. Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients. Science. 359(6371):97–103.
   PubMed Web of Science ®Google Scholar
• Graspeuntner S, Waschina S, Künzel S, Twisselmann N, Rausch TK, Cloppenborg-Schmidt K, Zimmermann J, Viemann D, Herting E, Göpel W, et al. 2019. Gut dysbiosis with bacilli dominance and accumulation of fermentation products precedes late-onset sepsis in preterm infants. Clin Infect Dis. 69(2):268–277.
   PubMed Web of Science ®Google Scholar
• Hanchi H, Mottawea W, Sebei K, Hammami R. 2018. The genus Enterococcus: between probiotic potential and safety concerns—an update. Front Microbiol. 9:1791.
   PubMed Web of Science ®Google Scholar
• He L, Yang H, Tang J, Liu Z, Chen Y, Lu B, He H, Tang S, Sun Y, Liu F, et al. 2019. Intestinal probiotics E. coli Nissle 1917 as a targeted vehicle for delivery of p53 and Tum-5 to solid tumors for cancer therapy. J Biol Eng. 13(1):58.
   PubMedGoogle Scholar
• Heintz-Buschart A, Pandey U, Wicke T, Sixel-Döring F, Janzen A, Sittig-Wiegand E, Trenkwalder C, Oertel WH, Mollenhauer B, Wilmes P. 2018. The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder. Mov Disord. 33(1):88–98.
   PubMed Web of Science ®Google Scholar
• Hill C, Guarner F, Reid G, Gibson GR, Merenstein DJ, Pot B, Morelli L, Canani RB, Flint HJ, Salminen S, et al. 2014. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat Rev Gastroenterol Hepatol. 11(8):506–514.
   PubMed Web of Science ®Google Scholar
• Kahouli I, Tomaro-Duchesneau C, Prakash S. 2013. Probiotics in colorectal cancer (CRC) with emphasis on mechanisms of action and current perspectives. J Med Microbiol. 62(Pt 8):1107–1123.
   PubMedGoogle Scholar
• Kanauchi O, Fukuda M, Matsumoto Y, Ishii S, Ozawa T, Shimizu M, Mitsuyama K, Andoh A. 2006. Eubacterium limosum ameliorates experimental colitis and metabolite of microbe attenuates colonic inflammatory action with increase of mucosal integrity. World J Gastroenterol. 12(7):1071–1077.
   PubMed Web of Science ®Google Scholar
• Kho ZY, Lal SK. 2018. The human gut microbiome – a potential controller of wellness and disease. Front Microbiol. 9:1835.
   PubMed Web of Science ®Google Scholar
• Kobashi K, Takeda Y, Itoh H, Hase J. 1983. Cholesterol-lowering effect of Clostridium butyricum in cholesterol-fed rats. Digestion. 26(4):173–178.
   PubMed Web of Science ®Google Scholar
• Kollath W. 1953. The increase of the diseases of civilization and their prevention. Munch Med Wochenschr. 95(47):1260–1262.
   PubMedGoogle Scholar
• Koo OK, Amalaradjou MAR, Bhunia AK. 2012. Recombinant probiotic expressing Listeria adhesion protein attenuates Listeria monocytogenes virulence in vitro. PLoS One. 7(1):e29277.
   PubMed Web of Science ®Google Scholar
• Koutsoumanis K, Allende A, Álvarez‐Ordóñez A, Bolton D, Bover‐Cid S, Chemaly M, Davies R, De Cesare A, Hilbert F, Lindqvist R, et al. 2019. Update of the list of QPS‐recommended biological agents intentionally added to food or feed as notified to EFSA 10: suitability of taxonomic units notified to EFSA until March 2019. EFSA J. 17(7):5753.
   Web of Science ®Google Scholar
• Kruisselbrink A, Heijne Den Bak‐Glashouwer MJ, Havenith CEG, Thole JER, Janssen R. 2001. Recombinant Lactobacillus plantarum inhibits house dust mite-specific T-cell responses. Clin Exp Immunol. 126(1):2–8.
   PubMed Web of Science ®Google Scholar
• Langella P, Chatel JM, Bermudez-Humaran L, Aubry C, Goffin L, Favre-Zimmerli S, Chvatchko Y. 2019. Lactococcus lactis producing TSLP or IL-25 and their uses as probiotics and therapeutics. United States patent US 10,238,697.
   Google Scholar
• Le Leu RK, Hu Y, Brown IL, Woodman RJ, Young GP. 2010. Synbiotic intervention of Bifidobacterium lactis and resistant starch protects against colorectal cancer development in rats. Carcinogenesis. 31(2):246–251.
   PubMed Web of Science ®Google Scholar
• LeCureux JS, Dean GA. 2018. Lactobacillus mucosal vaccine vectors: immune responses against bacterial and viral antigens. mSphere. 3(3):e00061-18.
   PubMed Web of Science ®Google Scholar
• Lee MF, Chiang CH, Lin SJ, Song PP, Liu HC, Wu TJ, Lin WW. 2020. Recombinant Lactococcus lactis expressing ling zhi 8 protein ameliorates nonalcoholic fatty liver and early atherogenesis in cholesterol-fed rabbits. Biomed Res Int. 2020:3495682.
   PubMed Web of Science ®Google Scholar
• Leenay RT, Vento JM, Shah M, Martino ME, Leulier F, Beisel CL. 2018. Streamlined, recombinase-free genome editing with CRISPR-Cas9 in Lactobacillus plantarum reveals barriers to efficient editing. bioRxiv, 352039.
   Google Scholar
• Leenay RT, Vento JM, Shah M, Martino ME, Leulier F, Beisel CL. 2019. Genome editing with CRISPR-Cas9 in Lactobacillus plantarum revealed that editing outcomes can vary across strains and between methods. Biotechnol J. 14(3):e1700583.
   PubMed Web of Science ®Google Scholar
• Li J, Lin S, Vanhoutte PM, Woo CW, Xu A. 2016. Akkermansia muciniphila protects against atherosclerosis by preventing metabolic endotoxemia-induced inflammation in Apoe–/– mice. Circulation. 133(24):2434–2446.
   PubMed Web of Science ®Google Scholar
• Li G, Ma C, Wang D, Chen W, Ma D. 2020. Recombinant Lactococcus lactis co-expressing dendritic cell target peptide and E. tenella 3-1E protein: immune response and efficacy against homologous challenge. Food Agric Immunol. 31(1):379–392.
   Web of Science ®Google Scholar
• Liu JJ, Reid G, Jiang Y, Turner MS, Tsai CC. 2007. Activity of HIV entry and fusion inhibitors expressed by the human vaginal colonizing probiotic Lactobacillus reuteri RC-14. Cell Microbiol. 9(1):120–130.
   PubMed Web of Science ®Google Scholar
• Li Q, Xu K, Du TAO, Zhu P, Verma A. 2018. Recombinant probiotics expressing angiotensin-(1-7) improves glucose metabolism and diabetes-induced renal and retinal injury. Diabetes. 67(Suppl. 1):33-LB.
   Google Scholar
• Lopez-Siles M, Duncan SH, Garcia-Gil LJ, Martinez-Medina M. 2017. Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics. ISME J. 11(4):841–852.
   PubMed Web of Science ®Google Scholar
• Lukiw WJ. 2016. Bacteroides fragilis lipopolysaccharide and inflammatory signaling in Alzheimer's disease. Front Microbiol. 7:1544.
   PubMed Web of Science ®Google Scholar
• Martín R, Miquel S, Benevides L, Bridonneau C, Robert V, Hudault S, Chain F, Berteau O, Azevedo V, Chatel JM, et al. 2017. Functional characterization of novel Faecalibacterium prausnitzii strains isolated from healthy volunteers: a step forward in the use of F. prausnitzii as a next-generation probiotic. Front Microbiol. 8:1226.
   PubMed Web of Science ®Google Scholar
• Matson V, Fessler J, Bao R, Chongsuwat T, Zha Y, Alegre ML, Luke JJ, Gajewski TF. 2018. The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients. Science. 359(6371):104–108.
   PubMed Web of Science ®Google Scholar
• Miquel S, Martin R, Rossi O, Bermudez-Humaran LG, Chatel JM, Sokol H, Thomas M, Wells JM, Langella P. 2013. Faecalibacterium prausnitzii and human intestinal health. Curr Opin Microbiol. 16(3):255–261.
   PubMed Web of Science ®Google Scholar
• Mohammadi E, Golchin M. 2020. High protection of mice against Brucella abortus by oral immunization with recombinant probiotic Lactobacillus casei vector vaccine, expressing the outer membrane protein OMP19 of Brucella species. Comp Immunol Microbiol Infect Dis. 70:101470.
   PubMed Web of Science ®Google Scholar
• Mohseni AH, Taghinezhad SS, Keyvani H. 2020. The first clinical use of a recombinant Lactococcus lactis expressing human papillomavirus type 16 E7 oncogene oral vaccine: a phase I safety and immunogenicity trial in healthy women volunteers. Mol Cancer Ther. 19(2):717–727.
   PubMed Web of Science ®Google Scholar
• Mulanovich VE, Desai PA, Popat UR. 2016. Allogeneic stem cell transplantation for HIV-positive patients with hematologic malignancies. AIDS. 30(17):2653–2657.
   PubMed Web of Science ®Google Scholar
• Okumura R, Takeda K. 2018. Maintenance of intestinal homeostasis by mucosal barriers. Inflamm Regen. 38:5.
   PubMed Web of Science ®Google Scholar
• O'Toole PW, Marchesi JR, Hill C. 2017. Next-generation probiotics: the spectrum from probiotics to live biotherapeutics. Nat Microbiol. 2:17057.
   PubMed Web of Science ®Google Scholar
• Ou B, Jiang B, Jin D, Yang Y, Zhang M, Zhang D, Zhao H, Xu M, Song H, Wu W, et al. 2020. Engineered recombinant Escherichia coli probiotic strains integrated with F4 and F18 fimbriae cluster genes in the chromosome and their assessment of immunogenic efficacy in vivo. ACS Synth Biol. 9(2):412–426.
   PubMed Web of Science ®Google Scholar
• Palma ML, Garcia-Bates TM, Martins FS, Douradinha B. 2019. Genetically engineered probiotic Saccharomyces cerevisiae strains mature human dendritic cells and stimulate Gag-specific memory CD8+ T cells ex vivo. Appl Microbiol Biotechnol. 103(13):5183–5192.
   PubMed Web of Science ®Google Scholar
• Park YJ, Kuen DS, Chung Y. 2018. Future prospects of immune checkpoint blockade in cancer: from response prediction to overcoming resistance. Exp Mol Med. 50(8):1–13.
   Google Scholar
• Paton AW, Jennings MP, Morona R, Wang H, Focareta A, Roddam LF, Paton JC. 2005. Recombinant probiotics for treatment and prevention of enterotoxigenic Escherichia coli diarrhea. Gastroenterology. 128(5):1219–1228.
   PubMed Web of Science ®Google Scholar
• Paton AW, Morona R, Paton JC. 2010. Bioengineered bugs expressing oligosaccharide receptor mimics: toxin-binding probiotics for treatment and prevention of enteric infections. Bioeng Bugs. 1(3):172–177.
   PubMedGoogle Scholar
• Pedersen HK, Gudmundsdottir V, Nielsen HB, Hyotylainen T, Nielsen T, Jensen BAH, Forslund K, Hildebrand F, Prifti E, Falony G, et al. 2016. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature. 535(7612):376–381.
   PubMed Web of Science ®Google Scholar
• Petrof EO, Khoruts A. 2014. From stool transplants to next-generation microbiota therapeutics. Gastroenterology. 146(6):1573–1582.
   PubMed Web of Science ®Google Scholar
• Pitt JM, Vetizou M, Gomperts Boneca I, Lepage P, Chamaillard M, Zitvogel L. 2017. Enhancing the clinical coverage and anticancer efficacy of immune checkpoint lockade through manipulation of the gut microbiota. OncoImmunology. 6(1):e1132137.
   PubMed Web of Science ®Google Scholar
• Pusch O, Kalyanaraman R, Tucker LD, Wells JM, Ramratnam B, Boden D. 2006. An anti-HIV microbicide engineered in commensal bacteria: secretion of HIV-1 fusion inhibitors by lactobacilli. AIDS. 20(15):1917–1922.
   PubMed Web of Science ®Google Scholar
• Ramakrishna C, Kujawski M, Chu H, Li L, Mazmanian SK, Cantin EM. 2019. Bacteroides fragilis polysaccharide A induces IL-10 secreting B and T cells that prevent viral encephalitis. Nat Commun. 10(1):2153.
   PubMedGoogle Scholar
• Rinninella E, Raoul P, Cintoni M, Franceschi F, Miggiano GAD, Gasbarrini A, Mele MC. 2019. What is the healthy gut microbiota composition? A changing ecosystem across age, environment, diet, and diseases. Microorganism. 7(1):14.
   PubMed Web of Science ®Google Scholar
• Roller M, Clune Y, Collins K, Rechkemmer G, Watzl B. 2007. Consumption of prebiotic inulin enriched with oligofructose in combination with the probiotics Lactobacillus rhamnosus and Bifidobacterium lactis has minor effects on selected immune parameters in polypectomised and colon cancer patients. Br J Nutr. 97(4):676–684.
   PubMed Web of Science ®Google Scholar
• Rong Y, Dong Z, Hong Z, Jin Y, Zhang W, Zhang B, Mao W, Kong H, Wang C, Yang B, et al. 2017. Reactivity toward Bifidobacterium longum and Enterococcus hirae demonstrate robust CD8+ T cell response and better prognosis in HBV-related hepatocellular carcinoma. Exp Cell Res. 358(2):352–359.
   PubMed Web of Science ®Google Scholar
• Ross JJ, Boucher PE, Bhattacharyya SP, Kopecko DJ, Sutkowski EM, Rohan PJ, Chandler DK, Vaillancourt J. 2008. Considerations in the development of live biotherapeutic products for clinical use. Curr Issues Mol Biol. 10(1–2):13–16.
   PubMedGoogle Scholar
• Rottiers P, Vandenbroucke K, Iserentant D. 2008. Use of recombinant yeast strain producing an anti-inflammatory compound to treat colitis. United States patent US 12/088,927.
   Google Scholar
• Routy B, Le Chatelier E, Derosa L, Duong CPM, Alou MT, Daillère R, Fluckiger A, Messaoudene M, Rauber C, Roberti MP, et al. 2018. Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors. Science. 359(6371):91–97.
   PubMed Web of Science ®Google Scholar
• Saarela MH. 2019. Safety aspects of next generation probiotics. Curr Opin Food Sci. 30:8–13.
   Web of Science ®Google Scholar
• Savoia C, Volpe M, Grassi G, Borghi C, Rosei EA, Touyz RM. 2017. Personalized medicine—a modern approach for the diagnosis and management of hypertension. Clin Sci (Lond). 131(22):2671–2685.
   PubMed Web of Science ®Google Scholar
• Schneeberger M, Everard A, Gomez-Valades AG, Matamoros S, Ramirez S, Delzenne NM, Gomis R, Claret M, Cani PD. 2015. Akkermansia muciniphila inversely correlates with the onset of inflammation, altered adipose tissue metabolism and metabolic disorders during obesity in mice. Sci Rep. 5:16643.
   PubMed Web of Science ®Google Scholar
• Sedwick C. 2014. A novel regulatory T cell population in the gut. PLoS Biol. 12(4):e1001834.
   PubMed Web of Science ®Google Scholar
• Selma MV, Beltrán D, Luna MC, Romo-Vaquero M, García-Villalba R, Mira A, Espín JC, Tomás-Barberán FA. 2017. Isolation of human intestinal bacteria capable of producing the bioactive metabolite isourolithin A from ellagic acid. Front Microbiol. 8:1521.
   PubMed Web of Science ®Google Scholar
• Shimbo I, Yamaguchi T, Odaka T, Nakajima K, Koide A, Koyama H, Saisho H. 2005. Effect of Clostridium butyricum on fecal flora in Helicobacter pylori eradication therapy. World J Gastroenterol. 11(47):7520–7524.
   PubMed Web of Science ®Google Scholar
• Shinnoh M, Horinaka M, Yasuda T, Yoshikawa S, Morita M, Yamada T, Miki T, Sakai T. 2013. Clostridium butyricum MIYAIRI 588 shows antitumor effects by enhancing the release of TRAIL from neutrophils through MMP-8. Int J Oncol. 42(3):903–911.
   PubMed Web of Science ®Google Scholar
• Simčič S, Berlec A, Stopinšek S, Štrukelj B, Orel R. 2019. Engineered and wild-type L. lactis promote anti-inflammatory cytokine signalling in inflammatory bowel disease patient’s mucosa. World J Microbiol Biotechnol. 35(3):45.
   PubMed Web of Science ®Google Scholar
• Sivan A, Corrales L, Hubert N, Williams JB, Aquino-Michaels K, Earley ZM, Benyamin FW, Lei YM, Jabri B, Alegre ML, et al. 2015. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science. 350(6264):1084–1089.
   PubMed Web of Science ®Google Scholar
• Syakila RN, Lim SM, Agatonovic-Kustrin S, Lim FT, Ramasamy K. 2019. In vitro assessment of pediococci- and lactobacilli-induced cholesterol-lowering effect using digitally enhanced high-performance thin-layer chromatography and confocal microscopy. Anal Bioanal Chem. 411(6):1181–1192.
   PubMed Web of Science ®Google Scholar
• Takeda Y, Itoh H, Kobashi K. 1983. Effect of Clostridium butyricum on the formation and dissolution of gallstones in experimental cholesterol cholelithiasis. Life Sci. 32(5):541–546.
   PubMed Web of Science ®Google Scholar
• Tan H, Wang C, Zhang Q, Tang X, Zhao J, Zhang H, Zhai Q, Chen W. 2020. Preliminary safety assessment of a new Bacteroides fragilis isolate. Food Chem Toxicol. 135:110934.
   PubMed Web of Science ®Google Scholar
• Tian Y, Li M, Song W, Jiang R, Li YQ. 2019. Effects of probiotics on chemotherapy in patients with lung cancer. Oncol Lett. 17(3):2836–2848.
   PubMed Web of Science ®Google Scholar
• Troy EB, Kasper DL. 2010. Beneficial effects of Bacteroides fragilis polysaccharides on the immune system. Front Biosci (Landmark Ed). 15:25–34.
   PubMed Web of Science ®Google Scholar
• Udayappan S, Manneras-Holm L, Chaplin-Scott A, Belzer C, Herrema H, Dallinga-Thie GM, Duncan SH, Stroes ESG, Groen AK, Flint HJ, et al. 2016. Oral treatment with Eubacterium hallii improves insulin sensitivity in db/db mice. NPJ Biofilms Microbiomes. 2:16009.
   PubMed Web of Science ®Google Scholar
• Ulsemer P, Henderson G, Toutounian K, Löffler A, Schmidt J, Karsten U, Blaut M, Goletz S. 2013. Specific humoral immune response to the Thomsen–Friedenreich tumor antigen (CD176) in mice after vaccination with the commensal bacterium Bacteroides ovatus D-6. Cancer Immunol Immunother. 62(5):875–887.
   PubMed Web of Science ®Google Scholar
• Ulsemer P, Toutounian K, Kressel G, Goletz C, Schmidt J, Karsten U, Hahn A, Goletz S. 2016. Impact of oral consumption of heat-treated Bacteroides xylanisolvens DSM 23964 on the level of natural TFα-specific antibodies in human adults. Benef Microbes. 7(4):485–500.
   PubMed Web of Science ®Google Scholar
• Ulsemer P, Toutounian K, Schmidt J, Karsten U, Goletz S. 2012. Preliminary safety evaluation of a new Bacteroides xylanisolvens isolate. Appl Environ Microbiol. 78(2):528–535.
   PubMed Web of Science ®Google Scholar
• US Food and Drug Administration. 2016. Early clinical trials with live biotherapeutic products: chemistry, manufacturing, and control information. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/early-clinical-trials-live-biotherapeutic-products-chemistry-manufacturing-and-control-information
   Google Scholar
• Verma A, Xu K, Du T, Zhu P, Liang Z, Liao S, Zhang J, Raizada MK, Grant MB, Li Q. 2019. Expression of human ACE2 in Lactobacillus and beneficial effects in diabetic retinopathy in mice. Mol Ther Methods Clin Dev. 14:161–170.
   PubMed Web of Science ®Google Scholar
• Wang B, Yao M, Lv L, Ling Z, Li L. 2017. The human microbiota in health and disease. Engineering. 3(1):71–82.
   Web of Science ®Google Scholar
• Watterlot L, Rochat T, Sokol H, Cherbuy C, Bouloufa I, Lefèvre F, Gratadoux J-J, Honvo-Hueto E, Chilmonczyk S, Blugeon S, et al. 2010. Intragastric administration of a superoxide dismutase-producing recombinant Lactobacillus casei BL23 strain attenuates DSS colitis in mice. Int J Food Microbiol. 144(1):35–41.
   PubMed Web of Science ®Google Scholar
• Wells J. 2011. Mucosal vaccination and therapy with genetically modified lactic acid bacteria. Annu Rev Food Sci Technol. 2:423–445.
   PubMed Web of Science ®Google Scholar
• Wells JM, Mercenier A. 2008. Mucosal delivery of therapeutic and prophylactic molecules using lactic acid bacteria. Nat Rev Microbiol. 6(5):349–362.
   PubMed Web of Science ®Google Scholar
• Woo TDH, Oka K, Takahashi M, Hojo F, Osaki T, Hanawa T, Kurata S, Yonezawa H, Kamiya S. 2011. Inhibition of the cytotoxic effect of Clostridium difficile in vitro by Clostridium butyricum MIYAIRI 588 strain. J Med Microbiol. 60(Pt 11):1617–1625.
   PubMed Web of Science ®Google Scholar
• Wrzosek L, Miquel S, Noordine ML, Bouet S, Chevalier-Curt MJ, Robert V, Philippe C, Bridonneau C, Cherbuy C, Robbe-Masselot C, et al. 2013. Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii influence the production of mucus glycans and the development of goblet cells in the colonic epithelium of a gnotobiotic model rodent. BMC Biol. 11:61.
   PubMed Web of Science ®Google Scholar
• Wu TR, Lin CS, Chang CJ, Lin TL, Martel J, Ko YF, Ojcius D, Lu CC, Young JD, Lai HC. 2019. Gut commensal Parabacteroides goldsteinii plays a predominant role in the anti-obesity effects of polysaccharides isolated from Hirsutella sinensis. Gut. 68(2):248–262.
   PubMed Web of Science ®Google Scholar
• Xu P, Wang Y, Tao L, Wu X, Wu W. 2019. Recombinant Lactococcus lactis secreting viral protein 1 of enterovirus 71 and its immunogenicity in mice. Biotechnol Lett. 41(6–7):867–872.
   PubMed Web of Science ®Google Scholar
• Yanagibashi T, Hosono A, Oyama A, Tsuda M, Suzuki A, Hachimura S, Takahashi Y, Momose Y, Itoh K, Hirayama K, Takahashia K, et al. 2013. IgA production in the large intestine is modulated by a different mechanism than in the small intestine: bacteroides acidifaciens promotes IgA production in the large intestine by inducing germinal center formation and increasing the number of IgA + B cells. Immunobiology. 218(4):645–651.
   PubMed Web of Science ®Google Scholar
• Yang JY, Lee YS, Kim Y, Lee SH, Ryu S, Fukuda S, Hase K, Yang CS, Lim HS, Kim MS, et al. 2017. Gut commensal Bacteroides acidifaciens prevents obesity and improves insulin sensitivity in mice. Mucosal Immunol. 10(1):104–116.
   PubMed Web of Science ®Google Scholar
• Zeng L, Tan J, Xue M, Liu L, Wang M, Liang L, Deng J, Chen W, Chen Y. 2020. An engineering probiotic producing defensin-5 ameliorating dextran sodium sulfate-induced mice colitis via Inhibiting NF-kB pathway. J Transl Med. 18(1):107.
   PubMed Web of Science ®Google Scholar